Milestone Pharmaceuticals IncNASDAQ:MIST
- LAST PRICE1.8700
- TODAY'S CHANGE (%)0.0300 (1.6304%)
- Bid / Lots1.8700/ 2
- Ask / Lots1.8900/ 7
- Open / Previous Close1.8500 / 1.8400
- Day Range
- 52 Week Range
- Volume324,717
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIST |
|---|---|---|
| 09:32 ET | 3690 | 1.88 |
| 09:42 ET | 500 | 1.8899 |
| 09:44 ET | 4700 | 1.88 |
| 09:46 ET | 1991 | 1.8701 |
| 09:48 ET | 400 | 1.875 |
| 09:50 ET | 400 | 1.875 |
| 09:53 ET | 1700 | 1.875 |
| 09:55 ET | 2800 | 1.87 |
| 10:02 ET | 151 | 1.88 |
| 10:04 ET | 250 | 1.88 |
| 10:09 ET | 14200 | 1.86 |
| 10:11 ET | 3000 | 1.86 |
| 10:13 ET | 2950 | 1.865 |
| 10:15 ET | 1407 | 1.8612 |
| 10:18 ET | 900 | 1.86 |
| 10:20 ET | 1200 | 1.86 |
| 10:22 ET | 2565 | 1.85 |
| 10:24 ET | 300 | 1.855 |
| 10:29 ET | 200 | 1.86 |
| 10:31 ET | 3400 | 1.86 |
| 10:33 ET | 1000 | 1.8559 |
| 10:36 ET | 400 | 1.86 |
| 10:40 ET | 1716 | 1.85 |
| 10:42 ET | 1060 | 1.867 |
| 10:45 ET | 200 | 1.85 |
| 10:54 ET | 1100 | 1.85 |
| 10:56 ET | 6624 | 1.86 |
| 10:58 ET | 1742 | 1.8587 |
| 11:00 ET | 200 | 1.855 |
| 11:02 ET | 1903 | 1.855 |
| 11:03 ET | 100 | 1.8575 |
| 11:05 ET | 242 | 1.859 |
| 11:07 ET | 650 | 1.855 |
| 11:09 ET | 300 | 1.85 |
| 11:12 ET | 10900 | 1.855 |
| 11:14 ET | 3725 | 1.855 |
| 11:16 ET | 3532 | 1.855 |
| 11:21 ET | 1000 | 1.85 |
| 11:23 ET | 64277 | 1.885 |
| 11:25 ET | 58165 | 1.885 |
| 11:27 ET | 3600 | 1.885 |
| 11:30 ET | 11221 | 1.885 |
| 11:32 ET | 8700 | 1.885 |
| 11:34 ET | 8700 | 1.885 |
| 11:36 ET | 2804 | 1.885 |
| 11:43 ET | 1064 | 1.89 |
| 11:45 ET | 700 | 1.885 |
| 11:48 ET | 1385 | 1.88 |
| 11:50 ET | 464 | 1.88 |
| 11:52 ET | 6427 | 1.88 |
| 11:54 ET | 1333 | 1.88 |
| 11:56 ET | 1910 | 1.87 |
| 11:57 ET | 402 | 1.87 |
| 11:59 ET | 400 | 1.87 |
| 12:01 ET | 3500 | 1.87 |
| 12:03 ET | 800 | 1.87 |
| 12:06 ET | 400 | 1.87 |
| 12:08 ET | 400 | 1.87 |
| 12:10 ET | 6375 | 1.88 |
| 12:12 ET | 5500 | 1.878 |
| 12:19 ET | 836 | 1.875 |
| 12:32 ET | 10474 | 1.86 |
| 12:33 ET | 1000 | 1.87 |
| 12:39 ET | 500 | 1.87 |
| 12:48 ET | 1630 | 1.87 |
| 12:55 ET | 2400 | 1.87 |
| 12:57 ET | 1000 | 1.87 |
| 01:02 ET | 300 | 1.8705 |
| 01:06 ET | 160 | 1.879 |
| 01:08 ET | 100 | 1.87 |
| 01:20 ET | 1000 | 1.87 |
| 01:26 ET | 6004 | 1.87 |
| 01:27 ET | 5000 | 1.8799 |
| 01:29 ET | 1275 | 1.88 |
| 01:31 ET | 1511 | 1.88 |
| 01:40 ET | 800 | 1.88 |
| 01:42 ET | 5300 | 1.88 |
| 01:47 ET | 5503 | 1.87 |
Today
Nov 12, 2024
Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update, from 9:03AM ET on Tuesday Nov 12, 2024 by Dow Jones
9:03AM ET on Tuesday Nov 12, 2024 by Dow Jones*DJ Milestone Pharmaceuticals 3Q Loss $9.44M >MIST, from 9:03AM ET on Tuesday Nov 12, 2024 by Dow Jones
9:03AM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Milestone Pharmaceuticals Inc | 98.0M | -2.3x | --- |
Oramed Pharmaceuticals Inc | 94.3M | 23.6x | --- |
Leap Therapeutics Inc | 97.6M | -1.3x | --- |
Nuvectis Pharma Inc | 98.5M | -4.3x | --- |
MediciNova Inc | 104.5M | -10.1x | --- |
Immunic Inc | 99.1M | -1.0x | --- |
Company Information
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
Contact Information
- Headquarters
- 420-1111 boul. Dr.-Frederik-PhilipsMONTREAL, QC, Canada H4M 2X6
- Phone
- 514-336-0444
- Fax
- 514-336-0444
Executives
- Non-Executive Independent Chairman of the Board
- Robert Wills
- President, Chief Executive Officer
- Joseph Oliveto
- Chief Financial Officer, Executive Vice President of Corporate Development
- Amit Hasija
- Chief Operating Officer
- Jeffrey Nelson
- Chief Medical Officer
- David Bharucha
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $98.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 53.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.79 |
EPS | $-0.81 |
Book Value | $0.50 |
P/E Ratio | -2.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
